14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
FUL vs SCL: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, H.B. Fuller Company (FUL) is the stronger overall head-to-head candidate over Stepan Co. (SCL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). FUL carries a Unified Composite Score of 37.4/100 (SELL) at $46.24 (9.0x Forward P/E, 12.0% operating margin), whereas SCL carries 41.5/100 (SELL) at $63.48 (18.0x Forward P/E, 3.5% operating margin).
Composite vs. Pillar Nuance: While SCL currently prints a higher short-term Unified Composite Score (41.5/100 SELL vs. FUL 37.4/100 SELL), FUL captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (12.0% vs. 3.5% operating margin) and revenue trajectory (+5.2% vs. +17.3% YoY).
Defensive Composite Rating Caution: Although FUL compares more favorably head-to-head, both FUL (37.4/100 SELL) and SCL (41.5/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: FUL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2); meanwhile SCL trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 40.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on FUL vs SCL. Trailing 12-month operating profitability (FUL 12.0% vs SCL 3.5%) and valuation multiples (FUL 9.0x vs SCL 18.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Specialty Chemicals value chain with $1.5B market capitalization and 3.5% operating margin.
OpEx & R&D Reinvestment8.5% of Rev ($215M)
90D Engineering Disclosures0 Published
Investor FAQ FUL vs SCL Key Questions & Quantitative Answers
As of Nov 20, 2026, H.B. Fuller Company (FUL) is the stronger overall head-to-head candidate over Stepan Co. (SCL) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). FUL carries a Unified Composite Score of 37.4/100 (SELL) at $46.24 (9.0x Forward P/E, 12.0% operating margin), whereas SCL carries 41.5/100 (SELL) at $63.48 (18.0x Forward P/E, 3.5% operating margin). Composite vs. Pillar Nuance: While SCL currently prints a higher short-term Unified Composite Score (41.5/100 SELL vs. FUL 37.4/100 SELL), FUL captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (12.0% vs. 3.5% operating margin) and revenue trajectory (+5.2% vs. +17.3% YoY). Defensive Composite Rating Caution: Although FUL compares more favorably head-to-head, both FUL (37.4/100 SELL) and SCL (41.5/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: FUL is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.2); meanwhile SCL trades in a Neutral technical trend (CONSOLIDATION options phase, RSI 40.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SCL leads the Growth & Scale pillar: FUL posts +5.2% YoY revenue growth and +18.0% YoY earnings growth on $3.55B TTM revenue (32.7% gross margin, 12.0% operating margin), compared with SCL at +17.3% YoY revenue growth and +65.5% YoY earnings growth on $2.53B TTM revenue (12.0% gross margin, 3.5% operating margin). On trailing 12-month operating scale, FUL generates $3.55B in USD-normalized revenue versus $2.53B for SCL. In operating R&D and SG&A reinvestment, FUL deploys 20.7% of Rev ($736M) (0 90-day corporate R&D disclosures) versus 8.5% of Rev ($215M) (0 disclosures) for SCL.
FUL screens cheaper on headline valuation multiples. FUL trades at 9.0x Forward P/E, 13.2x Trailing P/E, 2.20x PEG, and 0.7x EV/Revenue (17.2% EBITDA margin), whereas SCL trades at 18.0x Forward P/E, N/M Trailing P/E, 1.75x PEG, and 0.8x EV/Revenue (0.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against FUL (9.6% ROE) versus SCL (0.4% ROE) capital efficiency.
In options market volatility and institutional positioning, FUL carries 59.5% implied volatility (19th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.91β · 34% Vol realized risk). By comparison, SCL carries 33.5% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.55β · 32% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.